Lineage Cell Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Lineage Cell Therapeutics, Inc. (LCTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.10 million shares for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-09.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2015-11-09
- Lineage Cell Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2015-09-30 was 550.00K shares, a 168.29% increase year-over-year.
- Lineage Cell Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2015-06-30 was 110.00K shares.
- Lineage Cell Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2015-03-31 was 440.00K shares, a 63.49% decline year-over-year.
- Lineage Cell Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2014-09-30 was 205.00K shares, a 51.19% decline year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month |
|---|---|---|---|
| 2015-09-30 | 550.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | 660.00K shares derived: sum of 2 quarters · filed 2015-11-09 | 1.10M shares 10-Q · filed 2015-11-09 |
| 2015-06-30 | 110.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | 550.00K shares 10-Q · filed 2015-08-10 | |
| 2015-03-31 | 440.00K shares 10-Q · filed 2015-05-08 | ||
| 2014-09-30 | 205.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | 205.00K shares derived: sum of 2 quarters · filed 2015-11-09 | 1.41M shares 10-Q · filed 2015-11-09 |
| 2014-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | 1.21M shares 10-Q · filed 2015-08-10 | |
| 2014-03-31 | 1.21M shares 10-Q · filed 2015-05-08 | ||
| 2013-09-30 | 420.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | 485.00K shares derived: sum of 2 quarters · filed 2013-11-12 | 1.57M shares 10-Q · filed 2013-11-12 |
| 2013-06-30 | 65.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | 1.16M shares 10-Q · filed 2013-08-09 | |
| 2013-03-31 | 1.09M shares 10-Q · filed 2014-05-12 | ||
| 2012-09-30 | 150.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | 175.00K shares derived: sum of 2 quarters · filed 2013-11-12 | 280.00K shares 10-Q · filed 2013-11-12 |
| 2012-06-30 | 25.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | 130.00K shares 10-Q · filed 2013-08-09 | |
| 2012-03-31 | 105.00K shares 10-Q · filed 2013-05-10 | ||
| 2011-09-30 | 205.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | 301.59K shares 10-Q · filed 2012-11-09 | |
| 2011-06-30 | 96.59K shares 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |